Ligufalimab (Anti-CD47)
Ligufalimab (Anti-CD47) is a humanized immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47, with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.58 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2825 |
| Sku # | A2825-1mg*25 |
| Pricing | 1mg*25, $5070.00 |